Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Factors Predicting Short-Term Symptom Burden in Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy: A Real-World Study By the Gimema

Blood (2024) 144 (Supplement 1): 7823.

https://doi.org/10.1182/blood-2024-199498

Published: 2024

Journal Articles

Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema

Blood (2023) 142 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2023-180012

Published: 2023

Journal Articles

Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem

Blood (2021) 138 (Supplement 1): 3867.

https://doi.org/10.1182/blood-2021-154037

Published: 2021

Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2019) 134 (Supplement_1): 3254.

https://doi.org/10.1182/blood-2019-126118

Published: 2019

Journal Articles

Zinc Supplementation Improves T Cell Reconstitution after Allogeneic HSCT By Stimulating Endogenous Pathways of Thymic Regeneration

Lorenzo Iovino, MD, Kirsten Cooper, Sinéad Kinsella, MSc, PhD, Paul DeRoos, Reema Jain, PhD, Sara Galimberti, Enrico Orciuolo, PhD MD, Edoardo Benedetti, MD, Mario Petrini, PhD MD Prof, Jarrod A Dudakov, PhD

Blood (2018) 132 (Supplement 1): 3321.

https://doi.org/10.1182/blood-2018-99-112707

Published: 2018

Journal Articles

Prdi-BF-1 Strongly Detected in Active Multiple Myeloma By Droplet Digital PCR: A Comparison with Real-Time PCR

Gabriele Buda, PhD MD, Francesca Guerrini, Simone Pacini, Enrico Orciuolo, Sara Galimberti, PhD MD, Mario Petrini, PhD MD Prof

Blood (2017) 130 (Supplement 1): 5373.

https://doi.org/10.1182/blood.V130.Suppl_1.5373.5373

Published: 2017

Journal Articles

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Walter Bertolami, MD, Paola Anna Erba, Francesco Caracciolo, Edoardo Benedetti, MD, Enrico Orciuolo, Gabriele Buda, PhD MD, Riccardo Morganti, Sara Galimberti, PhD MD, Mario Petrini, PhD MD Prof

Blood (2017) 130 (Supplement 1): 5522.

https://doi.org/10.1182/blood.V130.Suppl_1.5522.5522

Published: 2017

Journal Articles

Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)

Lorenzo Iovino, MD, Federico Pratesi, BD, Francesco Mazziotta, MD, Enrico Orciuolo, PhD MD, Gabriele Buda, PhD MD, Edoardo Benedetti, MD, Mario Petrini, PhD MD Prof, Paola Migliorini, PhD MD Prof, Sara Galimberti, PhD MD

Blood (2017) 130 (Supplement 1): 1017.

https://doi.org/10.1182/blood.V130.Suppl_1.1017.1017

Published: 2017

Journal Articles

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Maria Ilaria Del Principe, Roberta di Blasi, MD, Luisa Verga, MD, Anna Candoni, MD, Stelvio Ballanti, MD, Leonardo Potenza, Chiara Cattaneo, MD, Mario Delia, MD, Nunzia Decembrino, MD, Lorella MA Melillo, MD, Carlo Castagnola, MD, Gianpaolo Nadali, MD, Rosa Fanci, MD, Antonella Ferrari, MD, Nicola Fracchiolla, MD, Enrico Orciuolo, PhD MD, Federica Lessi, MD, Anna Chierichini, MD, Massimo Offidani, MD, Marco Picardi, MD, Lucia Prezioso, MD, Benedetta Rambaldi, MD, Francesco Marchesi, MD, Ombretta Annibali, Daniele Zama, MD, Valentina Mancini, MD, Prassede Salutari, MD, Maria Grazia Garzia, MD, Adriana Vacca, MD, Simone Cesaro, MD, Rosangela Invernizzi, MD, Katia Perruccio, MD, Maria Enza Mitra, MD, Angela Maria Quinto, MD, Maria Chiara Tisi, Bruno Martino, Adriano Venditti, MD, Alessandro Busca, Franco Aversa, MD, Livio Pagano, MD

Blood (2017) 130 (Supplement 1): 5018.

https://doi.org/10.1182/blood.V130.Suppl_1.5018.5018

Published: 2017

Journal Articles

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Gabriele Buda, MD PhD, Rita Fazzi, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Paola Sammuri, Enrico Orciuolo, MD PhD, Iacopo Petrini, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Nicola Giuliani, Mario Petrini

Blood (2016) 128 (22): 5697.

https://doi.org/10.1182/blood.V128.22.5697.5697

Published: 2016

Journal Articles

Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+ NaϊVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study

Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Gabriele Buda, MD PhD, Giovanni Carulli, MD, Fabrizio Maggi, Dr, Daniele Focosi, MD, Riccardo Morganti, Dr, Francesca Guerrini, PhD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2016) 128 (22): 1230.

https://doi.org/10.1182/blood.V128.22.1230.1230

Published: 2016

Journal Articles

CD69 Expression Predicts Favorable Outcome in Multiple Myeloma Patients Treated with VTD

Gabriele Buda, MD, Giovanni Carulli, Enrico Orciuolo, Paola Sammuri, Sara Galimberti, MD, Martina Rousseau, MD, Francesca Martini, Mario Petrini

Blood (2015) 126 (23): 1768.

https://doi.org/10.1182/blood.V126.23.1768.1768

Published: 2015

Journal Articles

CD69, a New Potential Clinical Marker in Multiple Myeloma

Gabriele Buda, MD, Giovanni Carulli, Enrico Orciuolo, Paola Sammuri, Daniele Campa, PhD, Sara Galimberti, Mario Petrini, MD

Blood (2014) 124 (21): 2027.

https://doi.org/10.1182/blood.V124.21.2027.2027

Published: 2014

Journal Articles

Non Pegylated Liposomal Doxorubicin in Combination with Dexamethasone and Lenalidomide (RMD) Is Active in Advanced MM

Gabriele Buda, MD, Enrico Orciuolo, Martina Rousseau, Sara Galimberti, Nadia Cecconi, Mario Petrini, MD

Blood (2014) 124 (21): 5742.

https://doi.org/10.1182/blood.V124.21.5742.5742

Published: 2014

Journal Articles

Mini-Allogeneic Transplantation in Multiple Myeloma: A Single-Center Ten-Year Experience

Lorenzo Iovino, Enrico Orciuolo, Gabriele Buda, MD, Francesco Caracciolo, Francesco Mazziotta, Sara Galimberti, Mario Petrini, MD PhD, Edoardo Benedetti

Blood (2014) 124 (21): 5928.

https://doi.org/10.1182/blood.V124.21.5928.5928

Published: 2014

Journal Articles

VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients

Gabriele Buda, MD, Enrico Orciuolo, Sara Galimberti, Francesco Ghio, Mario Petrini, MD

Blood (2013) 122 (21): 5377.

https://doi.org/10.1182/blood.V122.21.5377.5377

Published: 2013

Journal Articles

Molecular Remission After VTD or TAD As Induction for Multiple Myeloma: Results with Two Different Methods of Analysis.

Gabriele Buda, Enrico Orciuolo, Giancarlo Carulli, Sara Galimberti, Mario Petrini, MD

Blood (2012) 120 (21): 2929.

https://doi.org/10.1182/blood.V120.21.2929.2929

Published: 2012

Journal Articles

R-CHOP21 Vs R-CHOP14 in 950 Diffuse Large B-Cell Lymphoma Patients: Results of a Multicentre Retrospective Study Form Italian Lymphoma Foundation (FIL)

Blood (2012) 120 (21): 1615.

https://doi.org/10.1182/blood.V120.21.1615.1615

Published: 2012

Journal Articles

Polymorphisms in Regulators of Xenobiotic Transport and Metabolism Genes NR1I2 and NR1I3 and Multiple Myeloma Risk: A Case-Control Study in the Context of IMMEnSE Consortium

Blood (2011) 118 (21): 5014.

https://doi.org/10.1182/blood.V118.21.5014.5014

Published: 2011

Journal Articles

R-CHOP21 Vs R-CHOP14 in Diffuse Large B-Cell Lymphoma Patients: Results From a Multicentre Retrospective Study

Luigi Rigacci, Alberto Fabbri, Benedetta Puccini, Enrico Orciuolo, Alice Pietrini, Lorenzo Iovino, Mario Petrini, MD, Francesco Lauria, MD, Alberto Bosi

Blood (2011) 118 (21): 1626.

https://doi.org/10.1182/blood.V118.21.1626.1626

Published: 2011

NARROW

Factors Predicting Short-Term Symptom Burden in Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy: A Real-World Study By the Gimema

Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema

Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Zinc Supplementation Improves T Cell Reconstitution after Allogeneic HSCT By Stimulating Endogenous Pathways of Thymic Regeneration

Prdi-BF-1 Strongly Detected in Active Multiple Myeloma By Droplet Digital PCR: A Comparison with Real-Time PCR

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+ NaϊVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study

CD69 Expression Predicts Favorable Outcome in Multiple Myeloma Patients Treated with VTD

CD69, a New Potential Clinical Marker in Multiple Myeloma

Non Pegylated Liposomal Doxorubicin in Combination with Dexamethasone and Lenalidomide (RMD) Is Active in Advanced MM

Mini-Allogeneic Transplantation in Multiple Myeloma: A Single-Center Ten-Year Experience

VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients

Molecular Remission After VTD or TAD As Induction for Multiple Myeloma: Results with Two Different Methods of Analysis.

R-CHOP21 Vs R-CHOP14 in 950 Diffuse Large B-Cell Lymphoma Patients: Results of a Multicentre Retrospective Study Form Italian Lymphoma Foundation (FIL)

Polymorphisms in Regulators of Xenobiotic Transport and Metabolism Genes NR1I2 and NR1I3 and Multiple Myeloma Risk: A Case-Control Study in the Context of IMMEnSE Consortium

R-CHOP21 Vs R-CHOP14 in Diffuse Large B-Cell Lymphoma Patients: Results From a Multicentre Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only